Genetic Requirements for the survival of Tubercle Bacilli in Nonhuman Primates

非人灵长类结核杆菌生存的遗传要求

基本信息

  • 批准号:
    8012717
  • 负责人:
  • 金额:
    $ 57.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-06-01 至 2015-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a global infectious disease emergency. Each year an estimated 8 million people develop, and about two million people die of TB. Synergy with AIDS, the emergence of drug-resistance and the lack of effective anti-TB drugs and vaccines has worsened this situation. New drugs and vaccines are urgently needed to effectively control TB. This requires a better understanding of how Mtb adapts to a wide-variety of environmental conditions, inevitably faced by it during the various stages of infection. Nonhuman Primates (NHPs), arguably, best model critical aspects of TB. Analysis of the mechanisms employed by Mtb to successfully infect and persist in NHP lungs would therefore be very useful. We studied genes essential for growth/survival of Mtb in the NHP lungs experimentally exposed to high doses of aerosols of an Mtb transposon mutant library. In this acute model of TB, 33.13% of all tested mutants were attenuated for in-vivo growth compared to the mouse model where only ~6% of all mutants are attenuated. The Mtb mutants attenuated for in-vivo survival in primates were involved in the transport of lipid virulence factors; biosynthesis of cell-wall arabinan and peptidoglycan, fatty-acids and polyketides; DNA repair; sterol metabolism and mammalian cell-entry (mce). Our study highlights the various virulence-mechanisms employed by Mtb for infection and to overcome the hostile environment encountered during infection of NHP lungs. We would like to leverage our ability to model the various clinical phases of human TB - acute, pulmonary TB, chronic-progressive TB and latent, asymptomatic TB in NHPs - to study the growth/survival phenotype profiles of Mtb mutants. Further, we would like to better understand the role of two Mtb pathways crucial for virulence and pathogenesis, using the NHP model. These include the mce1/mce4 operons, whose members were among mutants that were attenuated for growth in NHP lungs; and members of the dos regulon, which were surprisingly not attenuated in NHP lungs, in-spite of their well-defined roles in latency, persistence and defense against hypoxia. PUBLIC HEALTH RELEVANCE: Tuberculosis (TB) is a global emergency, responsible for the death of an estimated 2 million people annually. Monkeys, due to their genetic and physiological similarities to humans, are a very good animal system to model TB. Out of the several hundreds of genes present in the chromosome of the tubercle bacillus, we have determined which ones are needed to establish a successful infection in the lungs of monkeys. These results will be compared to those obtained from animals with TB/AIDS co-infection. Genes from the mce (mammalian cell entry) family were among those which were attenuated in the NHP lungs. We will perform functional studies using Mycobacterium tuberculosis (Mtb) and defined mutants in mce genes, using our monkey model, to better understand their role in disease process.
描述(由申请人提供):结核(TB)是由结核分枝杆菌(Mtb)引起的全球性突发传染病。每年估计有800万人患结核病,约200万人死于结核病。加上艾滋病、耐药性的出现以及缺乏有效的抗结核药物和疫苗,这种情况进一步恶化。为了有效控制结核病,迫切需要新的药物和疫苗。这需要更好地了解结核分枝杆菌如何适应在感染的各个阶段不可避免地面临的各种环境条件。可以说,非人类灵长类动物(NHPs)是结核病关键方面的最佳模型。因此,分析结核分枝杆菌成功感染并在NHP肺部持续存在的机制将是非常有用的。我们研究了Mtb在NHP肺中生长/存活所必需的基因,实验暴露于Mtb转座子突变文库的高剂量气溶胶中。在这个急性结核模型中,33.13%的所有测试突变体在体内生长时被减毒,而小鼠模型中只有6%的突变体被减毒。在灵长类动物体内减毒的Mtb突变体参与脂质毒力因子的转运;细胞壁阿拉伯聚糖、肽聚糖、脂肪酸和聚酮的生物合成;DNA修复;固醇代谢与哺乳动物细胞进入(mce)。我们的研究强调了结核分枝杆菌感染的各种毒力机制,并克服了NHP肺部感染期间遇到的敌对环境。我们希望利用我们的能力来模拟人类结核病的不同临床阶段——急性、肺结核、慢性进展性结核病和NHPs中的潜伏性、无症状结核病——来研究结核分枝杆菌突变体的生长/存活表型。此外,我们希望利用NHP模型更好地了解两种对毒力和发病机制至关重要的结核分枝杆菌途径的作用。这些包括mce1/mce4操纵子,其成员在NHP肺中生长的突变体中被减弱;以及dos调控的成员,令人惊讶的是,尽管它们在潜伏期、持久性和抗缺氧防御中有明确的作用,但在NHP肺中并未减弱。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Deepak Kaushal其他文献

Deepak Kaushal的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Deepak Kaushal', 18)}}的其他基金

Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis
诱导支气管相关淋巴组织在潜伏性结核病中的作用
  • 批准号:
    10764569
  • 财政年份:
    2023
  • 资助金额:
    $ 57.12万
  • 项目类别:
Basic Science Core - Imaging
基础科学核心 - 成像
  • 批准号:
    10588228
  • 财政年份:
    2022
  • 资助金额:
    $ 57.12万
  • 项目类别:
Basic Science Core - Imaging
基础科学核心 - 成像
  • 批准号:
    10431470
  • 财政年份:
    2022
  • 资助金额:
    $ 57.12万
  • 项目类别:
Baboon model of long term effects of SARS-CoV-2 infection
SARS-CoV-2 感染长期影响的狒狒模型
  • 批准号:
    10413419
  • 财政年份:
    2021
  • 资助金额:
    $ 57.12万
  • 项目类别:
Establishment of a SPF Rhesus Macaque Colony
SPF 恒河猴群落的建立
  • 批准号:
    10362396
  • 财政年份:
    2021
  • 资助金额:
    $ 57.12万
  • 项目类别:
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
结核病对 SIV 感染婴儿免疫系统发育和功能的影响
  • 批准号:
    10444441
  • 财政年份:
    2021
  • 资助金额:
    $ 57.12万
  • 项目类别:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
了解骨髓源性抑制细胞在结核病中的功能作用
  • 批准号:
    10757101
  • 财政年份:
    2020
  • 资助金额:
    $ 57.12万
  • 项目类别:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
了解骨髓源性抑制细胞在结核病中的功能作用
  • 批准号:
    10440359
  • 财政年份:
    2020
  • 资助金额:
    $ 57.12万
  • 项目类别:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
了解骨髓源性抑制细胞在结核病中的功能作用
  • 批准号:
    10211126
  • 财政年份:
    2020
  • 资助金额:
    $ 57.12万
  • 项目类别:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
了解骨髓源性抑制细胞在结核病中的功能作用
  • 批准号:
    10083390
  • 财政年份:
    2020
  • 资助金额:
    $ 57.12万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.12万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 57.12万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.12万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.12万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.12万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.12万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.12万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 57.12万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 57.12万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 57.12万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了